Table 2 Reasons dupilumab therapy was not started
Total submissions for coverage between Aug 18, 2020 and Sep 15, 2021 | 85 |
Insurance company did not consider coverage for dupilumab at the time of submission n (%) | 23 (27) |
Patient did not meet criteria for coverage | 1 (1.17) |
Other reasons therapy was not started | |
Patient did not want to exhaust lifetime maximum limit of policy | 1 (1.17) |
Medical conditions not related to CRSwNP | 3 (3.52) |
Patient did not want to pursue therapy | 5 (5.88) |
Application still in process | 10 (11.76) |